bibliographicCitation |
Davies GF, Khandelwal RL, Wu L, Juurlink BHJ, Roesler WJ. Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-γ (PPARγ)-independent, antioxidant-related mechanism11Abbreviations: BADGE, bisphenol A diglycidyl ether; DCF, dichlorofluorescein; DCFH, 5- (and 6-)carboxy-2′,7′-dichlorodihydrofluorescein; PEPCK, phosphoenolpyruvate carboxykinase; 15-PGJ2, 15-deoxy-Δ12,14-prostaglandin J2; PPAR, peroxisome proliferator-activated receptor; RPPO, ribosomal phosphoprotein PO; TZD, thiazolidinedione. Biochemical Pharmacology. 2001 Nov;62(8):1071–9. doi: 10.1016/s0006-2952(01)00764-x. |
title |
Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-γ (PPARγ)-independent, antioxidant-related mechanism11Abbreviations: BADGE, bisphenol A diglycidyl ether; DCF, dichlorofluorescein; DCFH, 5- (and 6-)carboxy-2′,7′-dichlorodihydrofluorescein; PEPCK, phosphoenolpyruvate carboxykinase; 15-PGJ2, 15-deoxy-Δ12,14-prostaglandin J2; PPAR, peroxisome proliferator-activated receptor; RPPO, ribosomal phosphoprotein PO; TZD, thiazolidinedione. |